A. Eden Evins

Zitiert von

	Alle	Seit 2017
Zitate	12536	5401
h-index	58	38
i10-index	129	108

1100

550

275

825

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202242 55 98 127 223 328 385 495 484 506 518 640 698 659 687 837 880 912 1035 1044 1004 511

Öffentlicher Zugriff

Alle anzeigen

100 Artikel

6 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Donald GoffNYU School of MedicineBestätigte E-Mail-Adresse bei nyumc.org
David Alan SchoenfeldProfessor of MedicineBestätigte E-Mail-Adresse bei partners.org
Fava, MMassachusetts General Hospital and Harvard Medical SchoolBestätigte E-Mail-Adresse bei partners.org
Jodi GilmanMassachusetts General Hospital/Harvard Medical SchoolBestätigte E-Mail-Adresse bei partners.org
Luke E. StoeckelDirector, Neuropsychology of Aging and Early AD/ADRD Program, NIA/NIHBestätigte E-Mail-Adresse bei nih.gov
Nancy A. RigottiProfessor of Medicine, Harvard Medical SchoolBestätigte E-Mail-Adresse bei partners.org
Diego A. PizzagalliHarvard Medical SchoolBestätigte E-Mail-Adresse bei mclean.harvard.edu
Randi SchusterMassachusetts General Hospital/Harvard Medical SchoolBestätigte E-Mail-Adresse bei mgh.harvard.edu
Xiaoduo FanUniversity of Massachusetts Medical SchoolBestätigte E-Mail-Adresse bei umassmed.edu
Marc J. KaufmanMcLean Hospital Harvard Medical SchoolBestätigte E-Mail-Adresse bei mclean.harvard.edu
Hoeppner SSBiostatistician, Department of Psychiatry, Massachusetts General HospitalBestätigte E-Mail-Adresse bei mgh.harvard.edu
Robert M. Anthenelli, M.D.Professor of Psychiatry, University of California, San DiegoBestätigte E-Mail-Adresse bei ucsd.edu
Blaise FrederickAssociate Professor of Psychiatry, Harvard Medical SchoolBestätigte E-Mail-Adresse bei mclean.harvard.edu
Robert WestUniversity College LondonBestätigte E-Mail-Adresse bei ucl.ac.uk
Vanessa CalderonDepartment of Psychology, University of Southern CaliforniaBestätigte E-Mail-Adresse bei usc.edu
Avram HolmesDepartment of Psychology, Yale UniversityBestätigte E-Mail-Adresse bei yale.edu
Eric AchtyesMichigan State UniversityBestätigte E-Mail-Adresse bei msu.edu
John F. Kelly, Ph.D.Elizabeth R. Spallin Professor of Psychiatry in the Field of Addiction Medicine, HarvardBestätigte E-Mail-Adresse bei mgh.harvard.edu
Bettina HoeppnerAssistant Professor, Massachusetts General Hospital, Harvard Medical SchoolBestätigte E-Mail-Adresse bei brown.edu
Susan whitfield-gabrieliMITBestätigte E-Mail-Adresse bei mit.edu

Folgen

A. Eden Evins

Mass General Hospital and Harvard Medical School

Bestätigte E-Mail-Adresse bei mgh.harvard.edu - Startseite

addiction medicine nicotine and cannabis use disorders smoking and vaping cessation cognitive function in schizophrenia


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised … RM Anthenelli, NL Benowitz, R West, L St Aubin, T McRae, D Lawrence, ... The Lancet 387 (10037), 2507-2520, 2016	833	2016
Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ... JAMA psychiatry 73 (3), 292-297, 2016	693	2016
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis DC Henderson, E Cagliero, PM Copeland, CP Borba, AE Evins, ... Archives of general psychiatry 62 (1), 19-28, 2005	485	2005
The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach M Fava, AE Evins, DJ Dorer, DA Schoenfeld Psychotherapy and psychosomatics 72 (3), 115-127, 2003	461	2003
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ... Journal of Clinical Psychiatry 66 (2), 183-194, 2005	436	2005
Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence AC Janes, DA Pizzagalli, S Richardt, BB Frederick, S Chuzi, G Pachas, ... Biological psychiatry 67 (8), 722-729, 2010	424	2010
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls RS Barr, MA Culhane, LE Jubelt, RS Mufti, MA Dyer, AP Weiss, ... Neuropsychopharmacology 33 (3), 480-490, 2008	289	2008
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness DA Pizzagalli, AE Evins, EC Schetter, MJ Frank, PE Pajtas, DL Santesso, ... Psychopharmacology 196 (2), 221-232, 2008	265	2008
Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study DC Henderson, DD Nguyen, PM Copeland, DL Hayden, CP Borba, ... Journal of Clinical Psychiatry 66 (9), 1116-1121, 2005	257	2005
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia AE Evins, VK Mays, C Cather, DC Goff, NA Rigotti, T Tisdale Nicotine & tobacco research 3 (4), 397-403, 2001	252	2001
Placebo-controlled trial of glycine added to clozapine in schizophrenia AE Evins, SM Fitzgerald, L Wine, R Rosselli, DC Goff American Journal of Psychiatry 157 (5), 826-828, 2000	245	2000
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ... Journal of clinical psychopharmacology 25 (3), 218-225, 2005	242	2005
Optimizing real time fMRI neurofeedback for therapeutic discovery and development LE Stoeckel, KA Garrison, SS Ghosh, P Wighton, CA Hanlon, JM Gilman, ... NeuroImage: Clinical 5, 245-255, 2014	235	2014
A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia DC Goff, DC Henderson, AE Evins, E Amico Biological psychiatry 45 (4), 512-514, 1999	222	1999
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial AE Evins, C Cather, SA Pratt, GN Pachas, SS Hoeppner, DC Goff, ... Jama 311 (2), 145-154, 2014	212	2014
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ... Journal of clinical psychopharmacology 27 (4), 380-386, 2007	202	2007
Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight O Freudenreich, C Cather, AE Evins, DC Henderson, DC Goff Journal of Clinical Psychiatry 65 (10), 1372-1376, 2004	191	2004
Opioid antagonists for smoking cessation SP David, T Lancaster, LF Stead, AE Evins, JJ Prochaska Cochrane Database of Systematic Reviews, 2013	186	2013
Folate, homocysteine, and negative symptoms in schizophrenia DC Goff, T Bottiglieri, E Arning, V Shih, O Freudenreich, AE Evins, ... American Journal of Psychiatry 161 (9), 1705-1708, 2004	170	2004
A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain DC Henderson, PM Copeland, TB Daley, CP Borba, C Cather, ... American Journal of Psychiatry 162 (5), 954-962, 2005	167	2005

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Diesem Autor folgen

Zitiert von

Koautoren